Arrowhead Pharmaceuticals, Inc. (ARWR)
63.60
-1.50
(-2.30%)
USD |
NASDAQ |
Mar 05, 16:00
63.60
0.00 (0.00%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Cash from Investing (TTM) : -229.95M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Sanofi | -2.854B |
| Eli Lilly & Co. | -10.97B |
| Sarepta Therapeutics, Inc. | 69.64M |
| Celcuity, Inc. | -129.93M |
| Cogent Biosciences, Inc. | -399.53M |